Misleading Data in The Clinical Trial is a Costly Mistake

The role of clinical data in the clinical trial process plays important role. The findings of the clinical trial has to be reported on timely basis which otherwise would lead into costly mistake raising the medical expenses of the patients. Most of the physicians and policy makers relay on the peer review publications to study about the clinical trial data, lack of information on the clinical trial would miss-lead the physicians to underestimate the effect of the drug and few estimate identical drug efficacy. You can also see the scenarios where some of the physicians estimate over efficiency of the drug. The unpublished clinical data is misleading the opinions of the physicians and leading into costly medical mistake. Many hurdles like lack of incentive to disseminate negative findings, time constraints, limited resources, changing interests and the article being rejected by the journal. 

One should take an extra effort publish the clinical trial data in order to keep the physicians keep guessing about the efficiency of the drug